Propiedad y actividad de insiders de Esperion Therapeutics, Inc. (ESPR): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $3.18 |
| Capitalización | $661M |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $38.2M | $34.5M | $37.0M | $166.1M | $305.0M | $208.9M | $124.8M | $82.2M | $144.8M | $167.9M |
| Inversiones a Corto | 0 | 0 | 0 | $34.7M | 0 | $50.4M | $42.1M | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | $12.4M | $22.9M | $33.7M | $48.5M | $80.1M | $140.2M |
| Inventario | 0 | 0 | 0 | 0 | $16.1M | $34.4M | $35.2M | $65.6M | $94.5M | $105.1M |
| Activos Corrientes | $213.6M | $203.9M | $142.6M | $211.7M | $345.9M | $329.0M | $246.7M | $201.1M | $338.0M | $462.6M |
| Inmovilizado Material | $674000 | $435000 | $520000 | $2.7M | $7.3M | $2.6M | $1.2M | $4.7M | $5.8M | $3.3M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $56000 | $56000 | $56000 | $56000 | $56000 | $56000 | $56000 | $56000 | $56000 | $56000 |
| Activos Totales | $245.2M | $277.8M | $143.5M | $214.4M | $353.3M | $381.6M | $247.9M | $205.8M | $343.8M | $465.9M |
| Cuentas por Pagar | $4.6M | $20.4M | $44.9M | $28.9M | $52.0M | $17.6M | $23.0M | $31.7M | $51.6M | $65.1M |
| Deuda a Corto | $1.7M | $1.0M | 0 | 0 | 0 | $12.7M | $25.1M | $34.8M | $102.2M | $89.7M |
| Pasivos Corrientes | $15.6M | $33.1M | $64.3M | $66.1M | $94.1M | $73.4M | $92.3M | $156.2M | $246.2M | $300.8M |
| Deuda a Largo | $1.0M | 0 | 0 | 0 | $179.4M | $258.3M | $259.9M | $501.5M | $483.7M | $457.6M |
| Pasivos Totales | $16.6M | $33.1M | $64.3M | $194.5M | $449.4M | $578.5M | $571.7M | $660.8M | $732.5M | $767.9M |
| Reservas | -$229.2M | -$396.3M | -$598.1M | -$695.3M | -$838.8M | -$1.11B | -$1.34B | -$1.55B | -$1.60B | -$1.62B |
| Patrimonio Neto | $228.6M | $244.7M | -$598.1M | $19.9M | -$96.1M | -$196.9M | -$323.8M | -$455.0M | -$388.7M | -$302.0M |
| Deuda Total | $2.7M | $1.0M | 0 | $1.6M | $185.4M | $260.2M | $260.9M | $540.9M | $591.2M | $548.0M |
| Deuda Neta | -$35.4M | -$33.4M | -$37.0M | -$199.2M | -$119.6M | $863000 | $94.1M | $458.7M | $446.5M | $380.1M |
| Capital Circulante | $198.0M | $170.8M | $78.3M | $145.6M | $251.8M | $255.6M | $154.4M | $44.8M | $91.8M | $161.8M |
Salud financiera
| Deuda / Patrimonio | -1.77 |
| Ratio corriente | 1.53 |
| Piotroski F-Score | 5 |
| Altman Z-Score | -2.57 |
Rentabilidad
| Rentabilidad sobre capital | 1.99% |
| Rentabilidad sobre capital invertido | 30.98% |
| Rentabilidad sobre activos | -1.60% |
| Margen bruto | 65.00% |
| Margen operativo | 18.12% |
| Margen neto | -1.77% |
Empresas relacionadas: AGIO · COLL · EBS · HRTX · KPTI · PTCT
Explorar sector: Healthcare · Biotechnology
Más secciones de ESPR: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones